ロード中...
MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer
BACKGROUND: Cancer cells exhibit an altered metabolism, which is characterized by a preference for aerobic glycolysis more than mitochondrial oxidation of pyruvate. Mitochondrial pyruvate carrier 1 (MPC1) and mitochondrial pyruvate carrier 2 (MPC2) play a bottleneck role by transporting pyruvate int...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5112705/ https://ncbi.nlm.nih.gov/pubmed/27852261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2941-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|